AUM $99.8MER 1.19%NAV $118.82Holdings 274Inception Apr 2010
Price Chart
Key Statistics
Previous Close
$125.19Day Range
$123.47$124.30
52-Week Range
$55.26$126.22
Avg Volume
15.0KDividend Yield
0.75%Expense Ratio
1.19%AUM
$99.8MShares Outstanding
810.0KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 53.68% |
| Cash & Others | 40.61% |
| Financial Services | 5.71% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 53.21% |
| Other | 40.45% |
| United Kingdom | 1.32% |
| Netherlands | 1.18% |
| Ireland | 0.95% |
| Denmark | 0.65% |
| France | 0.62% |
| Switzerland | 0.62% |
| Canada | 0.42% |
| Germany | 0.40% |
| Luxembourg | 0.05% |
| Australia | 0.03% |
| China | 0.03% |
| Spain | 0.03% |
| Israel | 0.02% |
| Belgium | 0.02% |
| Taiwan | 0.01% |
Fund Information
- Issuer
- ProShares
- Category
- Healthcare
- Inception Date
- Apr 7, 2010
- Exchange
- NASDAQ
- Description
- ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.
Similar ETFs
The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund issued by ProShares that launched on Apr 7, 2010. It currently manages $99.8M in assets under management. The fund charges an expense ratio of 1.19%. The fund holds 274 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 68.4% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | — | Net Other Assets (Liabilities) | 42.45% | 42,876,240 | $42.9M |
| 2 | IQMM | PROSHARES GENIUS MNY MKT ETF | 4.96% | 50,000 | $5.0M |
| 3 | AMGN | AMGEN INC | 4.54% | 10,635 | $4.6M |
| 4 | VRTX | VERTEX PHARMACEUTICALS INC | 4.28% | 8,005 | $4.3M |
| 5 | GILD | GILEAD SCIENCES INC | 3.78% | 26,648 | $3.8M |
| 6 | REGN | REGENERON PHARMACEUTICALS | 2.88% | 3,519 | $2.9M |
| 7 | MRNA | MODERNA INC | 1.79% | 13,562 | $1.8M |
| 8 | RVMD | REVOLUTION MEDICINES INC | 1.52% | 7,263 | $1.5M |
| 9 | ILMN | ILLUMINA INC | 1.09% | 5,171 | $1.1M |
| 10 | BIIB | BIOGEN INC | 1.07% | 5,045 | $1.1M |
| 11 | ALNY | ALNYLAM PHARMACEUTICALS INC | 1.04% | 4,561 | $1.0M |
| 12 | ARGX | ARGENX SE - ADR | 0.97% | 944 | $980K |
| 13 | INSM | INSMED INC | 0.92% | 7,407 | $926K |
| 14 | RPRX | ROYALTY PHARMA PLC- CL A | 0.91% | 15,152 | $918K |
| 15 | ROIV | ROIVANT SCIENCES LTD | 0.90% | 24,575 | $905K |
Page 1 of 6
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -1.37% | |
| 1W | +10.26% | |
| 1M | +25.23% | |
| 3M | +45.54% | |
| 6M | +40.07% | |
| YTD | +58.59% | |
| 1Y | +121.01% | |
| 3Y | +136.50% | |
| 5Y | +18.32% |
Moving Averages
20-Day MA
$108.97
Above 20-Day MA50-Day MA
$102.23
Above 50-Day MA200-Day MA
$86.39
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$126.22
Current Price
$123.47
52-Week Low
$55.26
$55.26$126.22
Current Yield
0.75%
Annual Dividend
$0.4570
Frequency
Quarterlyx/year
Last Ex-Date
Mar 25, 2026
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Mar 25, 2026 | $0.0071 | Mar 31, 2026 |
| Dec 24, 2025 | $0.1346 | Dec 31, 2025 |
| Dec 24, 2025 | $0.1346 | Dec 31, 2025 |
| Sep 24, 2025 | $0.1805 | Sep 30, 2025 |
| Sep 24, 2025 | $0.1805 | Sep 30, 2025 |
| Jun 25, 2025 | $0.1706 | Jul 1, 2025 |
| Jun 25, 2025 | $0.1706 | Jul 1, 2025 |
| Mar 26, 2025 | $0.1309 | Apr 1, 2025 |
| Mar 26, 2025 | $0.1309 | Apr 1, 2025 |
| Dec 23, 2024 | $0.3964 | Dec 31, 2024 |
| Dec 23, 2024 | $0.3964 | Dec 31, 2024 |
| Sep 25, 2024 | $0.1529 | Oct 2, 2024 |
| Sep 25, 2024 | $0.1528 | Oct 2, 2024 |
| Jun 26, 2024 | $0.2648 | Jul 3, 2024 |
| Jun 26, 2024 | $0.2648 | Jul 3, 2024 |
| Mar 20, 2024 | $0.0403 | Mar 27, 2024 |
| Dec 20, 2023 | $0.0384 | Dec 28, 2023 |
| Dec 22, 2022 | $0.0200 | Dec 30, 2022 |
| Dec 22, 2022 | $0.0199 | Dec 30, 2022 |
| Sep 21, 2010 | $0.0880 | Sep 28, 2010 |
Dividend Payments Over Time
Category Comparison
| Metric | BIB | Healthcare(223 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 1.19% | 0.62% | 0.84% |
| AUM | $99.8M | $1.98B | $1.86B |
| Dividend Yield | 0.75% | 3.90% | 1.97% |
| Avg Volume | 15.0K | 422.1K | 1.1M |
| Holdings | 274 | 167 | 65 |
| Performance | |||
| 1-Month Return | +29.58% | +6.56% | +11.19% |
| 6-Month Return | +48.39% | +16.09% | +26.77% |
| YTD Return | +56.92% | +16.75% | +27.34% |
| 1-Year Return | — | +15.10% | +23.91% |
Compare with Another ETF
Search for an ETF to compare with BIB:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.